Cytek Biosciences Inc (CTKB) — Financial Flexibility Index
Cytek Biosciences Inc (CTKB) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-568.00K (operating CF $-2.74 Million minus capex $2.17 Million) represents 0% of total liabilities ($121.47 Million). Check Cytek Biosciences Inc (CTKB) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytek Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Cytek Biosciences Inc across 7 annual periods. See how liquid is Cytek Biosciences Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cytek Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Cytek Biosciences Inc. For the full company profile including market capitalisation, see CTKB market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-602.00K | $-4.69 Million | $119.80 Million | ▼ -101.8% |
| 2024 | 0.28x | $28.90 Million | $25.38 Million | $103.76 Million | ▲ +179.4% |
| 2023 | 0.10x | $10.11 Million | $5.28 Million | $101.39 Million | ▲ +496.3% |
| 2022 | -0.03x | $-2.36 Million | $-12.23 Million | $93.93 Million | ▼ -116.2% |
| 2021 | 0.16x | $8.99 Million | $4.63 Million | $57.92 Million | ▲ +119.4% |
| 2020 | 0.07x | $16.70 Million | $15.16 Million | $236.01 Million | ▲ +162.1% |
| 2019 | -0.11x | $-12.77 Million | $-13.75 Million | $112.06 Million | — |